Dr. Wallace is Chief Scientific Officer at Peloton Therapeutics. From 2013 to 2015 he served as Vice President of Chemistry and from 2011 to 2013 as Director of Medicinal Chemistry. Prior to his tenure at Peloton, Dr. Wallace worked in the medicinal chemistry department at Array BioPharma Inc. where he rose through the ranks to Director. He led multiple research projects, which produced eight new chemical entities that have entered human clinical trials for the treatment of cancer. Previously, Dr. Wallace worked as a Medicinal Chemist at Ciba-Geigy (Novartis) and Glaxo Wellcome (GlaxoSmithKline). He earned a B.A. in chemistry from Lawrence University and a Ph.D. in organic chemistry from Colorado State University. Dr. Wallace was an NIH postdoctoral fellow at the University of South Carolina. He has co-authored 20 original research articles and invited reviews, and is co-inventor on 28 granted patents.